Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage

The American Journal of Medicine

Volumn 83, Issue 3 SUPPL. 2, 1987, Pages 74-82

  Caldwell, Jacques R ^a   Roth, Sanford H ^b   Wu, Wallace C ^c   Semble, Elliott L ^c   Castell, Donald O ^c   Heller, Matthew D ^d   Marsh, William H ^e  

^a UNIVERSITY OF FLORIDA   (United States)

^b St Luke's Medical Center   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Arthritis Associates Inc ^*  (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIFLUNISAL; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO; SALSALATE; SUCRALFATE; SULINDAC;

ADULT; AGED; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG THERAPY; ENDOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; STOMACH INJURY; STOMACH MUCOSA;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; CLINICAL TRIALS; DOUBLE-BLIND METHOD; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HUMAN; INTESTINAL MUCOSA; MALE; MIDDLE AGE; PATIENT COMPLIANCE; RANDOM ALLOCATION; SUCRALFATE; SUPPORT, NON-U.S. GOV'T;

EID: 0023634240     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(87)90832-1     Document Type: Article

References (32)

1. Utilization of nonsteroidal anti-inflammatory drugs
2. Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin
3. The effect of cimetidine on peptic ulceration in patients receiving anti-inflammatory therapy
4. Cimetidine in the treatment of gastric ulcer induced by steroidal and nonsteroidal anti-inflammatory agents
5. 2-blocker on gastric ulcers in patients taking aspirin: a double-blind study
6. Protection of gastric mucosa by sucralfate from aspirin-induced erosions
7. Comparison of sucralfate vs cimetidine in protection of the human gastric mucosa against alcohol injury
8. 2 synthesis—possible mechanism to explain its effective cytoprotective properties
9. The protective effect of sucralfate on the gastric mucosa of rats
10. Effect of sucralfate on ethanol-induced gastric mucosal damage in the rat
11. Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats
12. Nonsteroidal anti-inflammatory drugs
13. Nonsteroidal anti-inflammatory drugs
14. Drugs, gastritis, and peptic ulcer
15. The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy
16. Cimetidine in the treatment of duodenal ulcer
17. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
18. Pathogenesis of experimental gastromucosal injury
19. The effects of ibuprofen, indomethacin, aspirin, naproxen and placebo on the gastric mucosa of normal volunteers
20. An endoscopic evaluation of the effects of nonsteroidal anti-inflammatory drugs on the gastric mucosa
21. Effects of aspirin in gastric mucus secretion
22. The biosynthesis of intestinal mucus
23. Cytoprotection by prostaglandins in rats
24. Cytoprotection by prostaglandins
25. Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial
26. Efficacy of sucralfate for duodenal ulcers: multi-center double-blind trial
27. Short-term treatment with sucralfate or cimetidine in gastric ulcer: preliminary results of a controlled randomized trial
28. Trophic effect of long-term sucralfate on the gastric mucosa
29. Sucralfate protection of the gastric mucosa against ethanol-induced injury: prostaglandin-mediated process?
30. Stimulation of mucus output: a further mode of action of sucralfate
31. Gastric protection by sucralfate: role of mucus and prostaglandins
32. Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat